Myron Holubiak
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Myron Holubiak
Myron Holubiak is recorded as Chairman at Citius Pharmaceuticals, Inc. (CTXR). The proxy statement of Citius Pharmaceuticals, Inc. reports total compensation of $2,199,588 for Myron Holubiak in fiscal 2024, including a base salary of $450,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-05-01–present
-
Current
Start not stated–present
-
Start not stated–2021-12-20
Last confirmed by a filing; no departure on record
-
Start not stated–2021-12-20
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Citius Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Leonard Mazur CEO, Board Member
- Jaime Bartushak CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Citius Pharmaceuticals, Inc. (CTXR) | Executive Vice Chairman | $450,000 | $2,199,588 |
| 2023 | Citius Pharmaceuticals, Inc. (CTXR) | Executive Vice Chairman | $450,000 | $1,594,373 |
| 2022 | Citius Pharmaceuticals, Inc. (CTXR) | Executive Vice Chairman | $450,000 | $1,240,056 |
Recent activity
No call appearances or filed executive changes recorded yet.